Valued at USD 630.90 million in 2024, the folic acid market is projected to reach USD 659.50 million in 2025 and USD 993.53 million by 2034, growing at a CAGR of 4.7% during the forecast period 2025–2034. North America was the largest regional market in 2024. Folic acid is a B vitamin essential for DNA synthesis, cell division, and growth. Key players include BASF SE, DSM Nutritional Products, Merck KGaA, Lonza Group, Zydus Cadila, Emcure Pharmaceuticals, Medicamen Biotech Ltd., Jiangxi Tianxin Pharmaceutical Co. Ltd., Hebei Jiheng Group Pharmaceutical Co. Ltd., Xinfa Pharmaceutical Co. Ltd., Now Foods, GNC Holdings, Inc., Amway Corporation, Seppic SA (a subsidiary of Air Liquide), and Kirkman Group, Inc.

Prenatal Supplements Drive Core Demand

A major trend is rising demand for prenatal supplements, driven by folic acid’s role in reducing the risk of neural tube defects in newborns. The Centers for Disease Control and Prevention (CDC) recommends that women of childbearing age consume 400 micrograms of folic acid daily to support fetal health. This emphasis has increased incorporation into prenatal vitamins, now a key segment of the broader supplement market. The CDC found that neural tube defect rates decreased by nearly 35% in countries with fortification programs, fueling demand in both developed and developing markets.

Fortification Policies Shape Food Industry Demand

Folic acid fortification has become increasingly common as a preventive public health measure. Governments and regulators, particularly in North America and Europe, have mandated or encouraged fortification of staple foods such as bread and cereal. In the US, the Food and Drug Administration has mandated addition to certain grain products since 1998. The World Health Organization notes that around 80 countries have mandatory policies. Growing consumer preference for fortified foods and beverages over traditional supplements, especially where supplementation compliance is a challenge, continues to lift demand.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/folic-acid-market

Form Segmentation: Tablets Lead

By form type, the market comprises tablets, soft gels, lozenges, and others. Folic acid tablets hold the largest share because of widespread use and affordability in prescription and over-the-counter prenatal vitamins. Stable shelf life, cost-effectiveness, and ease of mass production enhance availability, particularly where healthcare initiatives prioritize access to essential supplements. Tablets are also customizable in dosage, allowing manufacturers to meet specific dietary requirements and medical guidance.

Application and Regional Insights

By application, pharmaceuticals hold the largest share, supported by use in prescription prenatal vitamins and public health campaigns, while nutraceuticals register the highest growth. Pharmaceuticals benefit from robust public health campaigns emphasizing preventive benefits. North America leads on regulatory mandates and strong public health focus, and a mature market for dietary supplements and fortified foods reinforces its position. In Europe, health awareness and government initiatives promote fortification, with the UK and Ireland implementing policies for maternal and child health. Asia Pacific is growing rapidly on awareness of nutritional deficiencies and expanding healthcare infrastructure in China and India.

Competitive Landscape and Developments

The competitive landscape mixes established pharmaceutical manufacturers with specialized nutraceutical companies. BASF SE and DSM Nutritional Products invest heavily in R&D for sustainable, bioavailable solutions, while companies pursue distribution expansion, partnerships, and acquisitions in emerging markets. Many companies focus on broadening distribution networks and enhancing product quality to meet regulatory standards and consumer preferences in various regions. In November 2024, the Department of Health (Northern Ireland) introduced legislation requiring folic acid in non-wholemeal flour to reduce spine and brain defects in newborns. Regulatory challenges remain a restraint.

Outlook for B2B Stakeholders

With a 4.7% CAGR ahead, suppliers aligned with prenatal supplements, folic acid fortification programs, and neural tube defects prevention are positioned for steady, policy-supported demand. Aging populations and an increasing focus on dietary supplements for overall health provide further support.

More Trending Latest Reports By Polaris Market Research:

photobook-and-album-market

translation-management-systems-market

contactless-connector-market

pre-owned-luxury-watches-market

aseptic-sampling-market

viral-clearance-market

matting-agents-market

dental-suture-market

flower-seed-market

power-scada-market